|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 47/64 | |
| A61K 39/09 |
| (11) | Patento numeris | 3104886 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 15710001.7 |
| Europos patento paraiškos padavimo data | 2015-02-06 | |
| (97) | Europos patento paraiškos paskelbimo data | 2016-12-21 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2018-10-17 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/IB2015/050919 |
| Data | 2015-02-06 |
| (87) | Numeris | WO 2015/121783 |
| Data | 2015-08-20 |
| (30) | Numeris | Data | Šalis |
| 201461939845 P | 2014-02-14 | US |
| (72) |
GU, Jianxin, US
KAINTHAN, Rajesh Kumar, US
KIM, Jin-Hwan, US
PRASAD, Avvari Krishna, US
YANG, Yu-ying, US
|
| (73) |
Pfizer Inc.,
235 East 42nd Street, New York, NY 10017,
US
|
| (54) | IMMUNOGENIC GLYCOPROTEIN CONJUGATES |
| IMMUNOGENIC GLYCOPROTEIN CONJUGATES |